Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
ten23 health, located in Basel and Visp, Switzerland, is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups: we develop, manufacture, and test modern medicines. We support our clients in developing differentiated, stable, usable, and safe injectable treatment options for patients. ten23 health combines the latest scientific findings with proven and tested world-class industry and regulatory expertise to forge new paths for supporting clients. We provide our innovative services in a fair and sustainable manner, respecting people’s health and the future of our planet. ten23 health is a B Corp member and solidly financed through the long-term commitment of 3i Group, an internationally reputable equity partner.
SC administration has been increasing over recent years, especially for frequent and long-term applications to treat chronical diseases.
Released By ten23 health
Enhance Cell Q’s capabilities to scale high-throughput sample prep, liquid-handling verification, COI/COC preservation, full-spectrum flow cytometry, and synthetic controls.
Wheeler Bio will provide integrated process development and cGMP drug substance manufacturing services.
New facilities will bridge R&D and manufacturing across both the U.S. and U.K.
New site will develop APIs in the U.S. for cancer, autoimmune and other advanced therapies.
ProBioGen will oversee the design, lead the construction, and subsequently operate the 4,600-square-meter GMP manufacturing unit.
By: Charlie Sternberg
CSL will pay VarmX shareholders $117 million upfront for an exclusive option to acquire the company.
Provides the Morgpeth facility’s Formulation Development Team with an important tool for developing fixed dose combinations and modified release drug delivery.
Bartley will lead day-to-day operations and growth across Chrysalis’ cleanroom infrastructure, environmental monitoring, and support service teams.
Maria Soler Nunez will take up the newly-created role of Chief Quality Officer.
Bilenberg is a seasoned industry executive with more than 20 years of experience.
Brings together professionals from across the drug development and manufacturing ecosystem.
Forms alliances with the Parker Institute for Cancer Immunotherapy and Children’s Hospital Los Angeles.
Matica Bio to provide analytical and downstream support that complements Cirsium's plant-based AAV technology.
Positions Seattle site as a premier destination for mammalian and microbial biologic production in the Pacific Northwest life sciences hub.
Together, the companies will integrate IND Drafting and CMC Support into Wheeler's ModularCMC Platform.
By: Rachel Klemovitch
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
